S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313

CompletedOBSERVATIONAL
Enrollment

2,100

Participants

Timeline

Start Date

July 17, 2006

Primary Completion Date

January 2, 2009

Study Completion Date

April 2, 2009

Conditions
Breast Cancer
Interventions
GENETIC

gene expression analysis

GENETIC

protein expression analysis

OTHER

fluorescent antibody technique

OTHER

laboratory biomarker analysis

Trial Locations (1)

06520-8028

Yale Cancer Center, New Haven

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

SWOG Cancer Research Network

NETWORK

NCT00896727 - S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313 | Biotech Hunter | Biotech Hunter